William E. Pelham Jr., an expert on attention deficit hyperactivity disorder, says he agrees with a recent Federal Drug Administration panel recommendation that Ritalin and other stimulant drugs used to treat ADHD should carry a warning about a possible link to an increased risk of death and injury.
William Pelham agrees with a recommendation by an FDA panel that Ritalin and other stimulant drugs used to treat ADHD carry a "black box warning."
The FDA's Drug Safety and Risk Management voted in favor of a "black box" warning—the FDA's strongest form of warning—for ADHD stimulant drugs after hearing testimony about the deaths of 25 people, including 19 children, who had taken the drugs.
Full Article
# posted by madthumbs @ 12:58 PM
